Brain Canada Brain Canada
FR Donate

Our directory of funded grants

343 result(s) found

Centre for Functional and Metabolic Mapping

Project Overview

The Centre for Functional and Metabolic Mapping (CFMM) at Western’s Robarts Research Institute houses Canada’s only collection of high-field (3T human) and ultra-high field (7T human and 9.4T animal) MR systems. The Centre is dedicated to establishing the anatomical, metabolic and functional cha…

See researchers on this project
Principal Investigator:
  • Ravi Menon, University of Western Ontario
Team Members:
  • Adrian Owen, University of Western Ontario
  • Stefan Everling, University of Western Ontario
  • Peter Williamson, London Health Sciences Centre
  • Stefan Kohler, University of Western Ontario
  • Rhodri Cusack, University of Western Ontario
  • Robert Bartha, Robarts Research Institute
  • Melvyn Goodale, University of Western Ontario
  • Steven Lomber, University of Western Ontario
  • Daniel Ansari, University of Western Ontario
  • Trevor Birmingham, University of Western Ontario
  • Amer Burhan, London Health Sciences Centre
  • Jorge Burneo, London Health Sciences Centre
  • Mel Boulton, London Health Sciences Centre
  • Michael Borrie, Parkwood Hospital
  • Arthur Brown, University of Western Ontario
  • Craig Campbell, London Health Sciences Centre
  • Dave Cechetto, University of Western Ontario
  • Blaine Chronik, University of Western Ontario
  • Brian Corneil, University of Western Ontario
  • Jody Culham, University of Western Ontario
  • Robert Cumming, University of Western Ontario
  • Sean Cregan, University of Western Ontario
  • Mark Daley, University of Western Ontario
  • Sandrine De Ribaupierre, University of Western Ontario
  • Greg Dekaban, University of Western Ontario
  • Maria Drangova, University of Western Ontario
  • Neil Duggal, University of Western Ontario
  • Aaron Fenster, University of Western Ontario
  • Davinia Fernandez-Espanjo, University of Western Ontario
  • Valter Feyles, University of Western Ontario
  • Elizabeth Finger, University of Western Ontario
  • Sandra Fisman, University of Western Ontario
  • Paul Frewen, University of Western Ontario
  • Al Getgood, University of Western Ontario
  • Karen Gordon, University of Western Ontario
  • Jessica Grahn, University of Western Ontario
  • Paul Gribble, University of Western Ontario
  • Elizabeth Hayden, University of Western Ontario
  • Robert Hegele, University of Western Ontario
  • David Holdsworth, University of Western Ontario
  • Murray Huff, University of Western Ontario
  • Chil Yong Kang, University of Western Ontario
  • Marc Joanisse, University of Western Ontario
  • Mandar Jog, London Health Sciences Centre
  • Ruth Lanius, London Health Sciences Centre
  • Andrew Leask, University of Western Ontario
  • Ting Lee, University of Western Ontario
  • Stan Leung, Western University
  • Ruth Martin, University of Western Ontario
  • Scott MacDougall/Shackleton, University of Western Ontario
  • Donna McBain, London Health Sciences Centre
  • Seyed Mirsattari, London Health Sciences Centre
  • Derek Mitchell, London Health Sciences Centre
  • Robert Nicolson, University of Western Ontario
  • Bruce Morton, Western University
  • JB Orange, University of Western Ontario
  • Tom Overend, University of Western Ontario
  • Terry Peters, University of Western Ontario
  • Marco Prado, University of Western Ontario
  • Raj Rajakumar, University of Western Ontario
  • Susanne Schmid, University of Western Ontario
  • Cheryle Seguin, University of Western Ontario
  • David Sherry, University of Western Ontario
  • Kevin Shoemaker, University of Western Ontario
  • Shiva Singh, University of Western Ontario
  • David Spence, University of Western Ontario
  • Femke Steijger, University of Western Ontario
  • Michael Strong, University of Western Ontario
  • Jean Theberge, St. Joseph's Hospital
  • Jonathan Thiessen, University of Western Ontario
  • Vilis Tutis, University of Western Ontario
  • Akshya Vasudev, University of Western Ontario
  • Tim Wilson, University of Western Ontario
  • Raymond Yee, University of Western Ontario
  • Barbara Fisher, Victoria Hospital, London Health Sciences Centre
  • Paula Foster, University of Western Ontario
  • Keith St. Lawrence, St. Joseph's Hospital
  • Darcy Fehlings, Holland Bloorview Kids Rehabilitation Hospital
  • A. Randy MacIntosh, Rotman Research Institute
  • Donald Welsh, University of Calgary
  • Brian MacVicar, University of British Columbia

CFMM: Canada’s National Ultra-High Field MRI Platform

Project Overview

Brain imaging using magnetic resonance imaging (MRI) is an essential tool in modern neuroscience, with many uses for examining brain structure and function in health and disease. The Centre for Functional and Metabolic Mapping (CFMM) at Western’s Robarts Research Institute houses Canada’s only c…

See researchers on this project
Principal Investigator:
  • Ravi Menon, University of Western Ontario
Team Members:
  • Robert Bartha, Robarts Research Institute
  • Stefan Everling, University of Western Ontario
  • Elizabeth Finger, University of Western Ontario
  • Adrian Owen, University of Western Ontario
  • Jody Culham, University of Western Ontario
  • Lena Palaniyappan, London Health Sciences Centre
  • Corey Baron, Western University
  • Marieke Mur, Western University
  • Ali Kahn, Western University

Challenging epigenetic hallmarks of aging in the choroid plexus to improve brain homeostasis

Project Overview

The choroid plexus (CP) is a secretory tissue found in each of the brain ventricles. The CP produces a clear fluid called cerebrospinal fluid (CSF) which helps to cushion the brain, to circulate nutrients, and remove waste from our brain. In addition, the CP secretes important molecules involved in …

See researchers on this project
Principal Investigator:
  • Benoit Laurent, Université de Sherbrooke

Characterization of a novel medulloblastoma tumor suppressor

Project Overview

Medulloblastoma is a pediatric cancer of the brain and is the most common solid tumour in children. Currently, the standard therapy for medulloblastoma remains nonspecific to the cancer subtype and consists of surgery followed by chemotherapy and/or craniospinal irradiation. Due to these treatments,…

See researchers on this project
Principal Investigator:
  • Sabrina Schlienger, IRCM

Characterization of MATR3 Mutations Associated with ALS

Project Overview

For this project, Dr. Park will examine how abnormalities in RNA binding proteins (RBPs) – in particular, one called Matrin 3 (MATR3) – can lead to ALS. MATR3 was discovered to be a genetic cause of ALS in 2014 and has yet to be studied in any detail. By creating the first-ever cell, fruit fly a…

See researchers on this project
Principal Investigator:
  • Jeehye Park,

    SickKids

Characterization of the role of LRRTMs in synaptic plasticity and memory formation

Project Overview

Dr. Connor’s projects have focused on elucidating the mechanisms governing synapse development, and how synaptic dysfunction is associated with neurologic disorders. Specifically, he has been investigating the role of synaptic adhesion proteins (SAPs), and uncovering the role of these proteins in …

See researchers on this project
Principal Investigator:
  • Steven Connor, University of British Columbia

Characterizing Enterovirus Disruption of Autophagy as a Disease Mechanism for ALS

Project Overview

A group of viruses called enteroviruses can cause a variety of infectious illnesses that are usually mild with symptoms that may include fever, respiratory distress, flu-like muscle aches and rashes. However, some enteroviruses are more serious, like enterovirus D68 that can cause severe respiratory…

See researchers on this project
Principal Investigator:
  • Yasir Mohamud, University of British Columbia - Providence Health Care Society

Characterizing the C9ORF72 protein interactome for identifying novel pathogenic pathways in ALS

Project Overview

In late 2011, a landmark discovery was made which identified that abnormalities (mutation) in a gene called C9ORF72 were responsible for the highest percentage of hereditary ALS and frontotemporal dementia cases. Since then, a lot of work has been done to understand how these mutations cause disease…

See researchers on this project
Principal Investigator:
  • Janice Robertson, University of Toronto

Characterizing the roles of synapse organizers in mediating synaptic function and brain-based diseases

Project Overview

The human brain is made up of neural circuits that are thought to underlie all brain function. These circuits are made up of contact points called synapses where individual nerve cells communicate with each other. For many years, scientists have been working to shed light on how nerve cells transm…

See researchers on this project
Principal Investigator:
  • Hong Lu, University of British Columbia

Circadian control of microglial activation in chronic pain states

Project Overview

Circadian, or 24-hour, rhythms control almost all biological systems in our bodies with sleep-wake cycles and body temperature control the best known examples. Interestingly, pain is also governed by these 24-hour rhythms. People suffering from chronic neuropathic pain have been found to rate their …

See researchers on this project
Principal Investigator:
  • Nader Ghasemlou, Queen's University

Closed-loop deep brain stimulation using chronic intracranial cortical sensing to inform subcortical stimulation delivery

Project Overview

Many patients with Parkinson’s disease experience freezing of gait (FoG), a debilitating symptom defined by “episodic absences or marked reduction of forward progression of the feet despite the intention to walk.” FoG can lead to reduced mobile independence and increased risk of falls, which c…

See researchers on this project
Principal Investigator:
  • Luka Milosevic, University Health Network

Co-clinical trials in mice and humans in autism

Project Overview

Autism has many causes, yet no single cause explains why many children and adults have autism. This makes treating the symptoms of autism difficult, since how somebody responds to treatment might depend on what cause autism in the first place. We thus need both better treatments and ways of figuring…

See researchers on this project
Principal Investigator:
  • Evdokia Anagnostou,

    Holland Bloorview Kids Rehabilitation Hospital

  • Jason Lerch, University of Toronto
Team Members:
  • Jane Foster, McMaster University
  • Barry Greenberg, Krembil Research Institute
  • Robert Nicolson, University of Western Ontario
  • Teresa Bennett, McMaster University
  • Rosanna Weksberg, The Hospital For Sick Children
  • Stephen Scherer, The Hospital For Sick Children

Co-clinical trials of autism in mice and humans

Project Overview

Autism is a neuro-developmental disorder characterized by social/communication deficits and repetitive behaviours. It is very heterogeneous, with over 250 genes implicated, but is highly heritable. The current therapeutic approach is frequently ineffective partly because often a single treatment is …

See researchers on this project
Principal Investigator:
  • Zsuzsa Lindenmaier,

    University of Toronto

Cognitive Outcomes and Response/Remission Efficacy of Convulsive Therapies in Treatment Resistant Depression: The CORRECT-TRD Trial

Project Overview

Magnetic Seizure Therapy (MST) is a novel form of treatment that uses high intensity magnetic field pulses to stimulate the brain and induce a seizure as a therapeutic intervention for patients with depression resistant to antidepressant medication, known as Treatment Resistant Depression (TRD). Pre…

See researchers on this project
Principal Investigator:
  • Daniel Blumberger, Centre for Addiction and Mental Health
Team Members:
  • Shawn McClintock, Duke University
  • Kiran Rabheru, University of Ottawa
  • Fidel Vila-Rodriguez, University of British Columbia
  • Zafiris Daskalakis, Centre for Addiction and Mental Health
  • Sarah Lisanby, Duke University
  • Mustafa Husain, Duke University
  • Jonathan Downar, Toronto Western Research Institute, University of Toronto

Combining neurostimulation technique with tailored interventions for the affected upper extremity: can it promote better recovery in stroke survivors?

Project Overview

A substantial proportion of individuals are left with poor residual functioning of the affected arm after a stroke. This has a tremendous impact on the quality of life and the ability for stroke survivors to live independently. While exercise is considered essential to any rehabilitation program, it…

See researchers on this project
Principal Investigator:
  • Marie-Hélène Milot, Université de Sherbrooke
Team Members:
  • François Tremblay, University of Ottawa
  • Marie-Hélène Boudrias, McGill University
  • Hélène Corriveau, Université de Sherbrooke

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

Project Overview

Amyotrophic lateral sclerosis (ALS) is a terminal disease that paralyzes people because the brain is no longer able to communicate with the muscles that we are typically able to move at will. One of the challenges is that ALS is a very heterogeneous disease, meaning that each person’s disease is d…

See researchers on this project
Principal Investigator:
  • Sanjay Kalra, University of Alberta
Team Members:
  • Nicolas Dupré, CRCHUQ-Enfant-Jesus, University Laval
  • Angela Genge, McGill University
  • Lorne Zinman, Sunnybrook Research Institute
  • Janice Robertson, University of Toronto
  • Christine Vande Velde, Université de Montréal
  • Ekaterina Rogaeva, University of Toronto
  • Tania Bubela, Simon Fraser University
  • Russell Greiner, University of Alberta
  • Wendy Johnston, University of Alberta

Correction of Neuronal Function in Autism

Project Overview

The prevalence of autism spectrum disorders (ASDs) is rising dramatically on a yearly basis and new interventional strategies are required to treat ASDs and related disorders like Fragile X syndrome. Altered communication between brain cells may lead to the defects responsible for the features that …

See researchers on this project
Principal Investigator:
  • Laurie Doering, McMaster University
Team Members:
  • Min Zhuo, University of Toronto
  • Ali Pejmun Haghighi, McGill University
  • David Nelson, Baylor College of Medicine

Cortical GABAergic interneurons migration impairment in genetic epileptic encephalopathies

Project Overview

This project aims at elucidating the roles of new candidate genes in brain development, particularly in the context of refractory paediatric epilepsies (epileptic encephalopathies) and co-morbid neurodevelopmental disorders such as autism and intellectual deficiency.  Lara Eid is particularly inter…

See researchers on this project
Principal Investigator:
  • Lara Eid, CHU-Saint Justine

CRF receptor-mediated sensitization of 5-HT2A receptor signalling

Project Overview

Anxiety and depression often present as co-morbid disorders and the expression and severity of these illnesses is commonly associated with stressful experiences. Both are widespread and serious disorders that affect the lives of 10-15% of Canadians for most of their lifetime. There are multiple pote…

See researchers on this project
Principal Investigator:
  • Cornelia Walther, University of Western Ontario